Current modalities for invasive and non-invasive monitoring of volume status in heart failure

Heart

Volumn 98, Issue 13, 2012, Pages 967-973

  Von Lueder, Thomas G ^a,b   Krum, Henry ^a  

^a MONASH UNIVERSITY   (Australia)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTERY CATHETERIZATION; BLOOD VOLUME; BODY FLUID; BODY WEIGHT; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATION; DETERIORATION; DISEASE COURSE; FOLLOW UP; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART RIGHT VENTRICLE PRESSURE; HEMODYNAMIC MONITORING; HOME MONITORING; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERVOLEMIA; IMPEDANCE CARDIOGRAPHY; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; LUNG ARTERY CATHETERIZATION; LUNG ARTERY PRESSURE; MEDICAL ASSESSMENT; NON INVASIVE MEASUREMENT; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOM; TELEMEDICINE; TELEMONITORING; TREATMENT OUTCOME; WEIGHT GAIN;

CARDIAC VOLUME; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HEART FAILURE; HUMANS; MONITORING, PHYSIOLOGIC; STROKE VOLUME;

EID: 84861999682     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301330     Document Type: Review

References (59)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011;123:e18-209.
2. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89.
3. Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace 2011;13(Suppl 2):ii13-17.
4. Pulignano G, Del Sindaco D, Tavazzi L, et al. Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 2002;143:45-55. (Pubitemid 34056374)
5. Blackledge HM, Tomlinson J, Squire IB. Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993e2001. Heart 2003;89:615-20. (Pubitemid 36606202)
6. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261:884-8. (Pubitemid 19046417)
7. Mahdyoon H, Klein R, Eyler W, et al. Radiographic pulmonary congestion in endstage congestive heart failure. Am J Cardiol 1989;63:625-7. (Pubitemid 19070125)
8. Friedman MM. Older adults' symptoms and their duration before hospitalization for heart failure. Heart Lung 1997;26:169-76. (Pubitemid 27232959)
9. Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and Btype natriuretic peptide in patients with pulmonary artery catheters. Circulation 2004;109:2432-9. (Pubitemid 38679564)
10. Daniels LB, Clopton P, Bhalla V, et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 2006;151:999-1005.
11. Chakko S, Woska D, Martinez H, et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 1991;90:353-9.
12. Felker GM, Hasselblad V, Hernandez AF, et al. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J 2009;158:422-30.
13. Porapakkham P, Zimmet H, Billah B, et al. B-type natriuretic peptide-guided heart failure therapy: a meta-analysis. Arch Intern Med 2010;170:507-14.
14. Adlbrecht C, Huelsmann M, Berger R, et al. Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse care. Eur J Clin Invest 2011;41:315-22.
15. Berger R, Moertl D, Peter S, et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol 2010;55:645-53.
16. Goldberg LR, Piette JD, Walsh MN, et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J 2003;146:705-12. (Pubitemid 37281718)
17. Mortara A, Pinna GD, Johnson P, et al. Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure). Eur J Heart Fail 2009;11:312-18.
18. Dar O, Riley J, Chapman C, et al. A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study. Eur J Heart Fail 2009;11:319-25.
19. Cleland JG, Louis AA, Rigby AS, et al. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 2005;45:1654-64. (Pubitemid 40704502)
20. Zhang J, Goode KM, Cuddihy PE, et al. Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study. Eur J Heart Fail 2009;11:420-7.
21. Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart failure. N Engl J Med 2010;363:2301-9.
22. Koehler F, Winkler S, Schieber M, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation 2011;123:1873-80.
23. Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010;8:CD007228.
24. Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112:841-8. (Pubitemid 41170070)
25. Maines M, Catanzariti D, Cemin C, et al. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case-control study. J Interv Card Electrophysiol 2007;19:201-7. (Pubitemid 47573216)
26. Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 2010;55:1803-10.
27. Abraham WT, Compton S, Haas G, et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail 2011;17:51-5.
28. Tomasi L, Zanotto G, Zanolla L, et al. Physiopathologic correlates of intrathoracic impedance in chronic heart failure patients. Pacing Clin Electrophysiol 2011;34:407-13.
29. Conraads VM, Tavazzi L, Santini M, et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 2011;32:2266-73.
30. van Veldhuisen DJ, Braunschweig F, Conraads V, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 2011;124:1719-26.
31. Brachmann J, Bohm M, Rybak K, et al. Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Heart Fail 2011;13:796-804.
32. Adamson PB, Magalski A, Braunschweig F, et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 2003;41:565-71. (Pubitemid 36223320)
33. Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 2008;51:1073-9. (Pubitemid 351374766)
34. Adamson PB, Conti JB, Smith AL, et al. Reducing events in patients with chronic heart failure (REDUCEhf) study design: continuous hemodynamic monitoring with an implantable defibrillator. Clin Cardiol 2007;30:567-75. (Pubitemid 350209968)
35. Adamson PB, Gold MR, Bourge RC, et al. Reducing decompensation events utilizing intracardiac pressures in patients with chronic HF (REDUCEhf). J Card Fail 2010;16:913.
36. Ritzema J, Troughton R, Melton I, et al. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation 2010;121:1086-95.
37. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;377:658-66.
38. Costanzo MR, Abraham WT, Adamson PB, et al. Medical management guided by pulmonary artery pressures in NYHA functional class III heart failure patients. J Card Fail 2011;17:S93.
39. Vollmann D, Nagele H, Schauerte P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J 2007;28:1835-40. (Pubitemid 47236638)
40. Ypenburg C, Bax JJ, van der Wall EE, et al. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol 2007;99:554-7. (Pubitemid 46215562)
41. Wang L, Lahtinen S, Lentz L, et al. Feasibility of using an implantable system to measure thoracic congestion in an ambulatory chronic heart failure canine model. Pacing Clin Electrophysiol 2005;28:404-11. (Pubitemid 40696301)
42. Rathman LD, Lee CS, Sarkar S, et al. A critical link between heart failure self-care and intrathoracic impedance. J Cardiovasc Nurs 2011;26:E20-6.
43. Sarkar S, Hettrick DA, Koehler J, et al. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices. J Card Fail 2011;17:569-76.
44. Braunschweig F, Ford I, Conraads V, et al. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). Eur J Heart Fail 2008;10:907-16.
45. Gore JM, Goldberg RJ, Spodick DH, et al. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest 1987;92:721-7. (Pubitemid 18000579)
46. Zion MM, Balkin J, Rosenmann D, et al. Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5,841 patients in the SPRINT Registry. SPRINT Study Group. Chest 1990;98:1331-5.
47. Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 1996;276:889-97. (Pubitemid 26301608)
48. Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005;294:1625-33.
49. Magalski A, Adamson P, Gadler F, et al. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail 2002;8:63-70. (Pubitemid 34521414)
50. Ritzema J, Melton IC, Richards AM, et al. Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device. Circulation 2007;116:2952-9. (Pubitemid 350291202)
51. Walton AS, Krum H. The Heartpod implantable heart failure therapy system. Heart Lung Circ 2005;14(Suppl 2):S31-3. (Pubitemid 43056013)
52. Zile MR, Bennett TD, St John Sutton M, et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008;118:1433-41.
53. Teerlink JR. Learning the points of COMPASS-HF: assessing implantable hemodynamic monitoring in heart failure patients. J Am Coll Cardiol 2008;51:1080-2.
54. Troughton RW, Ritzema J, Eigler NL, et al. Direct left atrial pressure monitoring in severe heart failure: long-term sensor performance. J Cardiovasc Transl Res 2011;4:3-13.
55. Adamson PB, Abraham WT, Aaron M, et al. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail 2011;17:3-10.
56. Krum H. Telemonitoring of fluid status in heart failure: CHAMPION. Lancet 2011;377:616-18.
57. Fallick C, Sobotka PA, Dunlap ME. Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation. Circ Heart Fail 2011;4:669-75.
58. Yancy CW, Lopatin M, Stevenson LW, et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006;47:76-84. (Pubitemid 43005168)
59. Ahmed A, Husain A, Love TE, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 2006;27:1431-9. (Pubitemid 43998077)